there are initial efficacy signs already and they are already indicating that it will go to phase 2b.... if the phase 2 a data is more promising than phase 1b then game on I would say
- Forums
- ASX - By Stock
- ATX
- Ann: Preliminary Final Report and Annual Report YE 31 March 2024
ATX
amplia therapeutics limited
Add to My Watchlist
1.04%
!
23.8¢

Ann: Preliminary Final Report and Annual Report YE 31 March 2024, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.8¢ |
Change
-0.003(1.04%) |
Mkt cap ! $116.7M |
Open | High | Low | Value | Volume |
24.5¢ | 24.5¢ | 23.8¢ | $900.9K | 3.728M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 248135 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 80927 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9000 | 0.240 |
17 | 296760 | 0.235 |
20 | 1428948 | 0.230 |
14 | 678777 | 0.225 |
17 | 444167 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 281774 | 15 |
0.250 | 657700 | 10 |
0.255 | 292994 | 8 |
0.260 | 270955 | 8 |
0.265 | 90420 | 2 |
Last trade - 15.49pm 31/07/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |